26
nanotimes
Companies Facts
cial Officer of The Dow Chemical Company. The Partners have already set priorities for joint potential projects. The emphasis will be on large-scale projects based on nanotechnologies with the aim of attracting cooperation from major corporations and regions in Russia and developing intellectual property.
Furthermore, Dow Chemical achieved sales of $13.8 billion in the fourth quarter of 2010, a 22% increase compared with the same period last year. Double-digit sales increases were also reported in all geographic areas, with the largest gain in North America (25%). On a geographic basis, double-digit volume growth was reported in all geographic areas except Asia Pacific, which was up 9%. Growth in the emerging geographies continued to be robust, par- ticularly for the Performance segments, which re- ported a combined 13% increase in volume. Volume growth also continued to be notable in Latin America and Eastern Europe, both of which reported double- digit increases.
Fourth Quarter 2010 Highlights:
The Company reported earnings of $0.37 per share, or $0.47 per share excluding certain items.(2) This compares with earnings of $0.08 per share in the year-ago period, or $0.18 per share excluding certain items.
Sales of $13.8 billion rose 22 percent versus the same quarter last year. Sales increased double-digits in all geographic areas and in all operating segments except Coatings and Infrastructure, which rose 6 percent.
Health and Agricultural Sciences posted record fourth quarter sales of $1.3 billion. Volume grew 20 percent with gains in every geographic area, led by 35 percent growth in Latin America.
Sales from emerging regions were $4.5 billion, reaching a new quarterly record for the Company. This was driven by volume growth in Thailand (33%), India (31%), Russia (30%), and Brazil (14%).
Net debt to total capitalization declined to 42.6%, 240 basis points below the Company‘s year-end goal. This was primarily due to $1.8 billion of cash flow from operating activities.
Equity earnings reached an all-time quarterly record of $313 million.
EBITDA(4) was $1.9 billion, an increase of 30 per- cent versus the year-ago period.
At the Company level, EBITDA margin expanded more than 200 basis points, representing the seventh consecutive quarter of year-over-year margin ex- pansion. Margin expanded in Plastics by 520 basis points. And Performance Products and Performance Systems together expanded margin by more than 230 basis points.
http://www.dow.com
E
.I. DuPont de Nemours and Company, Inc., and Evonik Degussa GmbH of Marl, Germany,
have signed a license agreement which solely grants DuPont worldwide access to the multi-shot or 2K molding technology patented by Evonik for nylon 6,6 and nylon 6. The licensed technology enables the eli- mination of process steps in the production of two-
11-02/03 :: February / March 2011
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95